Pentavac inj. susp. (pwdr. + susp.) i.m. pre-filled syr. vial

Land: Belgía

Tungumál: enska

Heimild: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Virkt innihaldsefni:

Poliovirus Type 1 (inactivated) 40 D-antigen U/1 dose; Bordetella Pertussis Toxoid (PT) 25 µg/dose; Conjugate of Haemophilus influenzae type b capsular polysaccharide and Tetanus toxoid 10 µg/dose; Bordetella Pertussis Filamentous Hemagglutinin (FHA) 25 µg/dose; Tetanus Toxoid >= 40 IU/dose; Poliovirus Type 3 (inactivated) 32 D-antigen U/1 dose; Diphtheria Toxoid (DT) >= 30 IU/dose; Poliovirus Type 2 (inactivated) 8 D-antigen U/1 dose

Fáanlegur frá:

Sanofi Pasteur Europe S.A.

ATC númer:

J07CA06

INN (Alþjóðlegt nafn):

Diphteria Antigen, Adsorbed; Haemophilus Influenzae Type b Polysaccharides, conjugated to tetanus toxoid; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins

Lyfjaform:

Powder and suspension for suspension for injection

Samsetning:

Diphteria Antigen, Adsorbed; Haemophilus Influenzae Type b Polysaccharides, conjugated to tetanus toxoid; Poliomyelitis Virus; Tetanus Toxoid Adsorbed; Bordetella Pertussis Antigen, Proteins

Stjórnsýsluleið:

Intramuscular use

Lækningarsvæði:

Diphtheria-Hemophilus Influenzae B-Pertussis-Poliomyelitis-Tetanus

Vörulýsing:

CTI code: 196131-02 - Pack size: 10 x 1 dose + 10 x 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 196131-01 - Pack size: 1 dose + 0.5 ml - Commercialisation status: NO - Delivery mode: Medical prescription

Leyfisstaða:

Commercialised: No

Leyfisdagur:

1998-11-03